Latchumanadhas Kalidoss/X
Sep 12, 2026, 13:43
Latchumanadhas Kalidoss: PETROS vs Infusion Thrombolysis in Mitral Valve Thrombosis
Latchumanadhas Kalidoss, Head of Laboratory at Madras Medical Mission, shared a post on X about a recent article he and his colleagues co-authored, published in The American Journal of Cardiology, adding:
“Largest worldwide single centre Obstructive mitral metallic valve thrombosis registry of 128 patients comparing infusion thrombolysis and PETROS procedeure from MMM.”
Title: Outcomes After Percutaneous Transcatheter Release Or Fibrinolysis For Obstructive Mechanical Mitral Valve Thrombosis
Authors: Nandhakumar Vasu, Latchumanadhas Kalidoss, Ashwini, Aashish Chopra, Harini Anandhan, Mullasari S Ajit
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 27, 2026, 16:13Lesley Van Wyk: DIC vs TTP vs HUS – The Key Diagnostic Clues
-
Oct 27, 2026, 16:02Ahmad G. Alzahrani: AF and Vascular Risk Factors – Should We Add Antiplatelet Therapy?
-
Oct 27, 2026, 16:02Iron Deficiency and Thrombocytosis: How Iron Availability Shapes Hematopoietic Lineage Decisions
-
Oct 27, 2026, 15:46Christiane Berger-Schaffitzel: New PhD Project Explores Snake Venom and Haemostasis
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results
-
Oct 27, 2026, 11:42Cece Calhoun: ASH Promotes Clinical Research Training and Mentorship for Emerging Hematologists
-
Oct 27, 2026, 11:41Ifeanyichukwu Ifechidere: The Laboratory Challenges of Measuring Direct Factor Xa Inhibitors